brain cancer

  •   George Lundberg, MD

    Research paper from Neuro-Oncology curated by Editor in Chief George Lundberg, MD, who notes: 

    Securing participation in clinical trials is a continuing and serious problem of clinical research for many cancers. This paper describes an effort to improve participation for brain cancer clinical trials.

    Go to full article published by Neuro-Oncology.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  •   George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD, who notes:

    DIPG is a rare, malignant brain tumor. Three hundred Americans, usually children, are diagnosed with DIPG each year. Its location (pons), its sublocation (intrinsic), its growth character (diffuse), and its cell type (glioma) describe a very difficult cancer to treat. Here is how one prestigious cancer center (Dana-Farber Cancer Institute) explains DIPG.